Get the Stockscreener App
75.35
1.05%
0.78
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $75.35, with a volume of 5.19M.
It is up +1.05% in the last 24 hours and down -3.61% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$74.57
Open:
$75.115
24h Volume:
5.19M
Relative Volume:
0.72
Market Cap:
$31.59B
Revenue:
$9.51B
Net Income/Loss:
$2.64B
P/E Ratio:
12.48
EPS:
6.0361
Net Cash Flow:
$2.14B
1W Performance:
-1.58%
1M Performance:
-3.61%
6M Performance:
-39.26%
1Y Performance:
-50.69%
1-Day Range:
$74.28
$76.06
1-Week Range:
$73.55
$76.50
52-Week Range:
$71.47
$160.48
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
75.35 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
17.24 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.78 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.81 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
528.47 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Unisphere Establishment Lowers Stock Position in Zoetis Inc. $ZTS - MarketBeat
Epoch Investment Partners Inc. Sells 52,935 Shares of Zoetis Inc. $ZTS - MarketBeat
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Supply Chain Digital
Arrowstreet Capital Limited Partnership Cuts Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Zoetis (ZTS) Launches New Pet Pain Treatments As Valuation Questions Return - simplywall.st
Zoetis: Sentiment Keeps Winning As Fundamentals Improve (NYSE:ZTS) - Seeking Alpha
Mizuho Markets Americas LLC Buys 386,100 Shares of Zoetis Inc. $ZTS - MarketBeat
Caxton Associates LLP Buys 31,646 Shares of Zoetis Inc. $ZTS - MarketBeat
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Temporary Concerns Present Entry Point in Zoetis (ZTS) - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming DeadlinesZTS - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Levin Capital Strategies L.P. Acquires New Holdings in Zoetis Inc. $ZTS - MarketBeat
ZOETIS DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Deadline Soon: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Zoetis (ZTS) Launches Two Long Acting Pet Pain Therapies In Canada And Europe - Yahoo! Finance Canada
ZOETIS INC. INVESTORS WITH LOSSES HAVE UNTIL JULY 27, 2026 - GlobeNewswire
Zoetis launches three-month osteoarthritis pain therapy for cats - Investing.com
Zoetis Launches Portela® (relfovetmab) in Canada and the European Union - Business Wire
Zoetis Inc. Stock 12‑Month Price Target Cut to $107.5, Implies 43% Upside - TradingView
Dimensional Fund Advisors LP Sells 63,039 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Lobbying Update: $300,000 of ZOETIS INC. lobbying was just disclosed - Quiver Quantitative
ZTS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ZTS Investors with Losses to Contact the Firm - Morningstar
Portnoy Law Firm Announces Class Action on Behalf of Zoetis, Inc. Investors - GlobeNewswire
SEB Asset Management AB Makes New $10.52 Million Investment in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Stake Lessened by KBC Group NV - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Geneos Wealth Management Inc. - MarketBeat
ZTS Stockholders Have Opportunity to Lead Zoetis Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel - GlobeNewswire
ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline - GlobeNewswire Inc.
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost - GlobeNewswire
ZTS Deadline: Rosen Law Firm Urges Zoetis Inc. (NYSE: ZTS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Joplin Globe
Zoetis Target of Unusually High Options Trading (NYSE:ZTS) - MarketBeat
Zoetis Inc (NYSE:ZTS): A Top Value Stock with Undervalued Strength - ChartMill
Meeder Asset Management Inc. Has $5.35 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Swiss National Bank Boosts Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (ZTS) Stock Analysis: Exploring a Potential 49.90% Upside in the Animal Health Sector - DirectorsTalk Interviews
Assetmark Inc. Increases Stake in Zoetis Inc. $ZTS - MarketBeat
ZTS Shareholders Have Opportunity to Lead Zoetis Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Zoetis says Neogen deal won't lessen competition after ACCC Phase 2 decision - MLex
Zoetis’ planned acquisition of Neogen attracts ACCC scrutiny - Beef Central
Price to book forward of Zoetis, Inc. Class A – MIL:1ZTS - TradingView
Zoetis purchase of Neogen unlikely to lessen sheep service competition - Sheep Central
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
ZTS Investors Have Opportunity to Lead Zoetis Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):